NL7309889A - - Google Patents

Info

Publication number
NL7309889A
NL7309889A NL7309889A NL7309889A NL7309889A NL 7309889 A NL7309889 A NL 7309889A NL 7309889 A NL7309889 A NL 7309889A NL 7309889 A NL7309889 A NL 7309889A NL 7309889 A NL7309889 A NL 7309889A
Authority
NL
Netherlands
Application number
NL7309889A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7309889A publication Critical patent/NL7309889A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D309/22Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7309889A 1972-07-19 1973-07-16 NL7309889A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2235406A DE2235406C3 (de) 1972-07-19 1972-07-19 2-Amino-4H-pyrane, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
NL7309889A true NL7309889A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-22

Family

ID=5851048

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7309889A NL7309889A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-19 1973-07-16

Country Status (27)

Country Link
US (1) US3897462A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JPS596873B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (3) ATA19475A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU468904B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE802496A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG22828A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA999299A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH597216A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS174214B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD109381A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2235406C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK132410C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES416988A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI58498C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2192842B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1402793A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU166811B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE38064B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL42745A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU68031A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7309889A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (2) NO138656C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL95715B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (2) RO62811A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE399259B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU466682A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA734890B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5919019U (ja) * 1982-07-29 1984-02-04 株式会社吉野工業所 化粧品容器
DE4429786A1 (de) * 1994-08-23 1996-02-29 Bayer Ag Verwendung von substituierten 6-Amino-4H-pyranen
DE19529859A1 (de) * 1995-08-14 1997-02-20 Bayer Ag Verwendung von Acyl-substituierten Aminopyranen
DE19529858A1 (de) * 1995-08-14 1997-02-20 Bayer Ag Substituierte 4H-Pyrane

Also Published As

Publication number Publication date
CA999299A (en) 1976-11-02
CH597216A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-03-31
JPS596873B2 (ja) 1984-02-15
RO62811A (fr) 1977-11-15
DD109381A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-11-05
IL42745A (en) 1976-12-31
FR2192842B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-07-15
IE38064B1 (en) 1977-12-21
ES442696A1 (es) 1977-04-16
HU166811B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-06-28
DE2235406C3 (de) 1982-01-07
IL42745A0 (en) 1973-10-25
FI58498C (fi) 1981-02-10
US3897462A (en) 1975-07-29
LU68031A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-09-17
NO772996L (no) 1974-01-22
FR2192842A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-02-15
NO138656B (no) 1978-07-10
IE38064L (en) 1974-01-19
DK132410C (da) 1976-05-03
FI58498B (fi) 1980-10-31
AU5825873A (en) 1975-01-23
NO139440B (no) 1978-12-04
AU468904B2 (en) 1976-01-29
NO138656C (no) 1978-10-18
CS174245B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-31
DK132410B (da) 1975-12-01
ATA638873A (de) 1975-03-15
SE399259B (sv) 1978-02-06
PL90876B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-02-28
ATA19475A (de) 1975-06-15
DE2235406A1 (de) 1974-02-07
CS174214B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-03-31
SU466682A3 (ru) 1975-04-05
AT326653B (de) 1975-12-29
BG22828A3 (bg) 1977-04-20
GB1402793A (en) 1975-08-13
AT328443B (de) 1976-03-25
BE802496A (fr) 1974-01-18
JPS56108784A (en) 1981-08-28
JPS4955670A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-05-30
PL95715B1 (pl) 1977-11-30
ES416988A1 (es) 1976-06-01
RO63583A (fr) 1978-08-15
ZA734890B (en) 1974-06-26
DE2235406B2 (de) 1981-01-22
NO139440C (no) 1979-03-14
JPS597714B2 (ja) 1984-02-20

Similar Documents

Publication Publication Date Title
CS172257B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2193624A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS172396B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS171749B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS172474B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN139458B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2201646A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2192842B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4988112U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2170341A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS496315A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2208284A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4994005A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4884783A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5151844Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5219706Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS160019B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS168145B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159839B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS157805B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS159955B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS49100615U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS4980377U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS155083B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS157287B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed